Division of Gastroenterology, Boston Children's Hospital, Boston, Massachusetts, USA; Esophageal Atresia Treatment Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Department of Surgery, Boston Children's Hospital, Boston, Massachusetts, USA; Esophageal Atresia Treatment Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Gastrointest Endosc. 2014 Aug;80(2):246-52. doi: 10.1016/j.gie.2014.01.033. Epub 2014 Mar 18.
We investigated whether removable stents, such as self-expandable plastic stents (SEPSs) and fully covered self-expandable metal stents (FCSEMSs) could provide an alternative treatment for recalcitrant strictures and esophageal perforations after esophageal atresia (EA) repair.
The primary aim of our study was to evaluate technical feasibility. Secondary aims were to evaluate safety and procedural success.
Retrospective study.
Tertiary-care referral center.
A total of 24 children with EA.
Retrospective review of all children with EA who underwent dilation and esophageal stent placement from January 2010 to February 2013 at our institution.
Healing of perforation and stricture resolution at 30 and 90 days.
A total of 41 stents (SEPSs 14, FCSEMSs 27) were placed in 24 patients with EA during the study period, including 14 who had developed esophageal leaks. Procedural success of esophageal stent placement in the treatment of refractory strictures was 39% at 30 days and 26% at 90 days. The success rate was 80% for closure of esophageal perforations with stent therapy after dilation and 25% for perforations associated with surgical repair. Adverse events of stent placement included migration (21% of SEPSs and 7% of FCSEMSs), granulation tissue (37% of FCSEMSs), and deep ulcerations (22% of FCSEMSs).
Retrospective study with small sample size.
SEPSs and FCSEMSs can be placed successfully in small infants and children with a history of EA repair. The stents appear to be safe and beneficial in closing esophageal perforations, especially post-dilation. However, a high stricture recurrence rate after stent removal may limit their usefulness in treating recalcitrant esophageal anastomotic strictures.
我们研究了可移除支架(如自膨式塑料支架 [SEPS] 和全覆膜自膨式金属支架 [FCSEMS])是否可作为食管闭锁(EA)修复后难治性狭窄和食管穿孔的替代治疗方法。
本研究的主要目的是评估技术可行性。次要目标是评估安全性和程序成功率。
回顾性研究。
三级转诊中心。
共 24 例 EA 患儿。
回顾性分析我院 2010 年 1 月至 2013 年 2 月期间所有接受扩张和食管支架置入术的 EA 患儿。
穿孔愈合和狭窄缓解情况,分别在 30 天和 90 天评估。
研究期间,共有 24 例 EA 患儿共放置 41 枚支架(SEPS 14 枚,FCSEMS 27 枚),其中 14 例发生食管漏。30 天时,难治性狭窄食管支架置入的程序成功率为 39%,90 天时为 26%。支架治疗扩张后食管穿孔的闭合成功率为 80%,与手术修复相关的穿孔为 25%。支架放置的不良事件包括移位(SEPS 为 21%,FCSEMS 为 7%)、肉芽组织(FCSEMS 为 37%)和深溃疡(FCSEMS 为 22%)。
样本量小的回顾性研究。
SEPS 和 FCSEMS 可成功放置于有 EA 修复史的小婴儿和儿童中。这些支架在闭合食管穿孔方面似乎是安全且有益的,尤其是在扩张后。然而,支架移除后狭窄复发率高可能限制了其在治疗难治性食管吻合口狭窄中的作用。